BDBM50070294 CHEMBL20165::N-[3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl]-2-(4-hydroxy-2-methyl-pyrrolidin-2-yl)-acetamide
SMILES: Cc1cn(C2CC(O)C(CNC(=O)CC3(C)CC(O)CN3)O2)c(=O)[nH]c1=O
InChI Key: InChIKey=QQJZDXXMFYEMRX-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase (Human immunodeficiency virus 1) | BDBM50070294 (CHEMBL20165 | N-[3-Hydroxy-5-(5-methyl-2,4-dioxo-3...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >5.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Wales Cardiff Curated by ChEMBL | Assay Description Concentration required for no significant inhibitory activity against HIV-1 reverse transcriptase | Bioorg Med Chem Lett 8: 1211-4 (1999) BindingDB Entry DOI: 10.7270/Q2PZ580P | |||||||||||
More data for this Ligand-Target Pair |